According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ29.39. In 2022 the company made an earnings per share (EPS) of ยฃ31.88 a decrease over its 2021 EPS that were of ยฃ60.14.